11-56743106-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005284.2(OR9G4):āc.661A>Gā(p.Ile221Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000279 in 1,613,984 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005284.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR9G4 | NM_001005284.2 | c.661A>G | p.Ile221Val | missense_variant | 2/2 | ENST00000641668.1 | |
OR9G4 | NM_001390832.1 | c.661A>G | p.Ile221Val | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR9G4 | ENST00000641668.1 | c.661A>G | p.Ile221Val | missense_variant | 2/2 | NM_001005284.2 | P1 | ||
OR9G4 | ENST00000641581.1 | c.661A>G | p.Ile221Val | missense_variant | 2/2 | P1 | |||
OR9G4 | ENST00000641505.1 | n.647A>G | non_coding_transcript_exon_variant | 2/2 | |||||
OR9G4 | ENST00000641980.1 | n.644A>G | non_coding_transcript_exon_variant | 2/2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152108Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251484Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135914
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461876Hom.: 0 Cov.: 33 AF XY: 0.00000825 AC XY: 6AN XY: 727242
GnomAD4 genome AF: 0.000191 AC: 29AN: 152108Hom.: 0 Cov.: 33 AF XY: 0.000162 AC XY: 12AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.706A>G (p.I236V) alteration is located in exon 1 (coding exon 1) of the OR9G4 gene. This alteration results from a A to G substitution at nucleotide position 706, causing the isoleucine (I) at amino acid position 236 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at